ELVN
Enliven Therapeutics Inc.
Latest News for ELVN
In a report released today, Soumit Roy from JonesTrading maintained a Buy rating on Enliven Therapeutics, with a price target of $45.00. According ......
LifeSci Capital analyst Sam Slutsky maintained a Buy rating on Enliven Therapeutics today and set a price target of $53.00. According to TipRanks, ......
LifeSci Capital analyst Sam Slutsky maintained a Buy rating on Enliven Therapeutics today and set a price target of $53.00. According to TipRanks, ......
Analysts have been eager to weigh in on the Healthcare sector with new ratings on BioAge Labs, Inc. (BIOA) and Enliven Therapeutics (ELVN). BioAge ......
News data is sourced from MarketXLS API and updated regularly.
Showing 4 of 4 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ELVN | $45.68 | +6.4% | 2.06M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Enliven Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW